Pediatric Blood & Cancer

Cover image for Vol. 62 Issue 9

Edited By: Peter E. Newburger, M.D.

Impact Factor: 2.386

ISI Journal Citation Reports © Ranking: 2014: 27/119 (Pediatrics); 37/68 (Hematology); 128/211 (Oncology)

Online ISSN: 1545-5017

Featured Cover Images

  • Volume 62 Issue 7 Cover Image

    Volume 62 Issue 7 Cover Image

    Frontocerebellar fiber tracking is displayed. A volume delineated by the frontal cerebral pole, the interhemispheric fissure, and the temporal pole was defined as seed ROI, while a cubic volume that included the entire cerebellum was set as target ROI (see Patients and Methods Section). A and B show sagittal views of the tract volume, C and D show axial views. Color in A and C encodes the direction of fiber pathways (green: anterior-posterior, blue: cranio-caudal, red: left-right).

  • Volume 62 Issue 6 Cover Image

    Volume 62 Issue 6 Cover Image

    (A) Bone marrow aspiration showed megaloblastic erythropoiesis (upper and lower left), apoptotic normoblasts (upper right), dysplastic myelopoiesis (lower left: large metamyelocyte) and micromegakaryocytes (lower right). (B) Brain MRI showing hypomyelination as previously described for folate malabsorption syndromes. In the T2-weighted axial MRI of the patient at the age of 15 months myelination is restricted to the corpus callosum and the periventricular white matter demonstrating a delay in myelination of about 8–9 months. MRI spectroscopy showed normal concentrations of inositol and choline.

  • Volume 62 Issue 5 Cover Image

    Volume 62 Issue 5 Cover Image

    Time course of TTP relapses and treatments. Vertical arrows indicate relapses; open boxes, treatments other than rituximab; stars, treatments with rituximab; triangle, splenectomy; open horizontal arrows, times in remission; LFU, lost to follow-up.

  • Volume 62 Issue 4 Cover Image

    Volume 62 Issue 4 Cover Image

    (A) NK cell interaction with antigen (Ag) on tumor cell. Both inhibitory and stimulatory ligands are shown. (B) Antigen presentation to a T-cell in the context of MHC class I. (C) Chimeric Antigen Receptor (CAR). (D) Bi-specific T-cell Engager (BiTE). CTL, cytotoxic T-lymphocyte; TCR, T-cell receptor; β-2-m, beta-2-microglobulin; Ag, antigen; KIR, Killer cell immunoglobulin-like receptor; scFvAb, single chain variable fragment of antibody.

  • Volume 62 Issue 7 Cover Image
  • Volume 62 Issue 6 Cover Image
  • Volume 62 Issue 5 Cover Image
  • Volume 62 Issue 4 Cover Image

Recently Published Issues

See all

Pediatric Blood & Cancer Goes Green

Get PBC Content Alerts

Access Pediatric Blood & Cancer research faster.

Sign up for Pediatric Blood & Cancer email table of content alerts and be the first to know when new research has published. Why sign up?

  • It’s Free – you don’t have to have a subscription to receive email table of content alerts.
  • Convenient Delivery Format – each alert is delivered straight to your inbox. Read immediately or file to read at your leisure.
  • User-Friendly – as each issue publishes, you get an at-a-glance listing of new content with direct links to the full-text of each article.
  • Saves You Time – email table of content alerts allow you to keep up to date with issues as they publish, saving you valuable research time.
  • No Commitment – you can opt-out of receiving email table of content alerts at any time, no questions asked.

1. Create an account, or ensure that you are logged into your Wiley Online Library account, using the box at the top right of the screen

2. Click on the icon (like the image below) in the 'JOURNAL TOOLS' menu at top left

Get New Content Alerts


3. The text next to the icon will change to: 'Alert Added to My Profile'

Official Journal of:

Join Us!

ASPHO
SIOP

News

Journal News

With sorrow, Pediatric Blood & Cancer editors and staff announce the sudden death of Bob Arceci, who was struck and killed while riding his motorcycle to work on Monday, June 8. This is a profound loss for his family, his patients, and his many friends and colleagues, as well as for Pediatric Blood and Cancer. Bob will be sorely missed; his contributions to pediatric hematology/oncology were many and diverse. He was a brilliant investigator, a superb clinician, an outstanding mentor, and an expert journal editor. His wisdom and wit guided the journal from infancy to its current position of prominence to readers, researchers, practitioners, and patients worldwide.

SEARCH

SEARCH BY CITATION